首页> 外文OA文献 >Urinary Exosome Based Androgen Receptor Variant 7 Detection in Metastatic Castration Resistant Prostate Cancer Patient

【2h】

Urinary Exosome Based Androgen Receptor Variant 7 Detection in Metastatic Castration Resistant Prostate Cancer Patient

机译：基于尿的外部雄激素受体变体7检测转移阉割前列腺癌患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chao Wang; Xiang Liu; Hongyan Li; Libo Zhao; Guanyi Kong; Jing Chen; Zhi Li; Jianfei Qi; Ye Tian; Fengbo Zhang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149–56. AR-V7 Testing: What's in it for the Patient? [J] . Jun Luo, Brandon Luber, Hao Wang, European urology . 2017,第6期

机译：回复Julie Steinestel，Christof Bernemann，Andres J. Schrader，Jochen K. Lennerz的信Re：Emmanuel S. Antonarakis，ChangXue Lu，Brandon Luber等。雄激素受体剪接变异-7 mRNA检测在用第一和二线依甲酰丁酰胺处理的转移性阉割前列腺癌循环肿瘤细胞中的胃泌素受体剪接变异-7mRNA检测。 J Clin incol 2017; 35：2149-56。 AR-V7测试：患者中有什么？
2. Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer [J] . Taplin Mary-Ellen, Antonarakis Emmanuel S., Ferrante Karen J., European urology . 2019,第6期

机译：雄激素受体调节针对响应性变体进行优化：A阶段3，随机试验在雄激素受体接头变体-7表达转移性阉割前列腺前列腺癌中
3. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide [J] . Antonarakis Emmanuel S., Lu Changxue, Luber Brandon, Journal of Clinical Oncology . 2017,第19期

机译：雄激素受体剪接变异-7 mRNA检测在用第一和二线止水剂和依甲酰胺治疗的转移阉割前列腺癌循环肿瘤细胞中患者肿瘤细胞的临床意义
4. Androgen Receptor Deregulation and the Transition to Castration Resistance in Prostate Cancer: Mechanisms and Potential Therapeutic Implications [C] . Karen E. Knudsen Genitourinary Cancers Symposium . 2011

机译：雄激素受体放松调节和前列腺癌抗阉割性的过渡：机制和潜在的治疗意义
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Role of Circulating Tumor Cells (CTC) Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients [O] . Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, 2019

机译：循环肿瘤细胞（CTC）雄激素受体全长（AR-FL）和雄激素受体剪接变体7（AR-V7）在去势抵抗性转移性前列腺癌患者的预期队列中的作用
7. Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry [O] . Malou C.P. Kuppen, Hans M. Westgeest, Alphonsus J.M. van den Eertwegh, 2019

机译：序列雄激素受体的现实世界结果靶向有或没有插入的寿命抵抗前列腺癌中的寿命延长药物：荷兰阉割前列腺癌登记处的结果

Urinary Exosome Based Androgen Receptor Variant 7 Detection in Metastatic Castration Resistant Prostate Cancer Patient

著录项

引文网络

相似文献

相关主题

期刊订阅